Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 5:08 pm Sale | 2025-09-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Commodore Capital LP | 3,028,335 4.600% | -321,665 (-9.60%) | Filing History |
| 2025-11-14 5:02 pm Sale | 2025-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | Commodore Capital LP | 3,780,055 4.900% | -69,945 (-1.82%) | Filing History |
| 2025-11-14 4:57 pm Purchase | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 10,208,060 7.200% | 3,800,000 (+59.30%) | Filing History |
| 2025-11-14 4:51 pm Purchase | 2025-09-30 | 13G | TERNS PHARMACEUTICALS INC TERN | Commodore Capital LP | 5,700,000 6.500% | 1,050,000 (+22.58%) | Filing History |
| 2025-11-14 4:39 pm Sale | 2025-09-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Commodore Capital LP | 585,000 2.000% | -590,000 (-50.21%) | Filing History |
| 2025-11-14 4:35 pm Purchase | 2025-09-30 | 13G | TYRA BIOSCIENCES INC TYRA | Commodore Capital LP | 3,375,000 6.300% | 625,000 (+22.73%) | Filing History |
| 2025-11-14 4:30 pm Purchase | 2025-09-30 | 13G | RELAY THERAPEUTICS INC RLAY | Commodore Capital LP | 17,000,000 9.900% | 3,650,000 (+27.34%) | Filing History |
| 2025-10-27 4:02 pm Purchase | 2025-10-20 | 13G | ALTO NEUROSCIENCE INC ANRO | Commodore Capital LP | 3,190,267 9.800% | 3,190,267 (New Position) | Filing History |
| 2025-10-08 4:09 pm Purchase | 2025-10-01 | 13G | PALISADE BIO INC COM P PALI | Commodore Capital LP | 9,690,665 9.900% | 9,690,665 (New Position) | Filing History |
| 2025-10-03 4:05 pm Purchase | 2025-09-26 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Commodore Capital LP | 4,522,977 9.900% | 2,691,231 (+146.92%) | Filing History |
| 2025-09-18 4:01 pm Purchase | 2025-09-11 | 13G | LB PHARMACEUTICALS INC LBRX | Commodore Capital LP | 1,225,000 5.500% | 1,225,000 (New Position) | Filing History |
| 2025-09-16 6:00 pm Purchase | 2025-09-09 | 13G | TERNS PHARMACEUTICALS INC TERN | Commodore Capital LP | 4,650,000 5.300% | 4,650,000 (New Position) | Filing History |
| 2025-08-15 4:01 pm Purchase | 2025-08-08 | 13G | ASSEMBLY BIOSCIENCES INC N ASMB | Commodore Capital LP | 1,615,981 9.900% | 1,615,981 (New Position) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-07-07 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 6,408,060 5.500% | 1,138,836 (+21.61%) | Filing History |
| 2025-08-14 5:07 pm Sale | 2025-06-30 | 13G | SOLID BIOSCIENCES INC SLDB | Commodore Capital LP | 0 0.000% | -5,825,000 (Position Closed) | Filing History |
| 2025-08-14 5:07 pm Purchase | 2025-06-30 | 13G | RELAY THERAPEUTICS INC RLAY | Commodore Capital LP | 13,350,000 7.800% | 3,350,000 (+33.50%) | Filing History |
| 2025-08-14 5:07 pm Sale | 2025-06-30 | 13G | NEUROGENE INC NGNE | Commodore Capital LP | 427,866 3.000% | -372,134 (-46.52%) | Filing History |
| 2025-08-14 5:06 pm Sale | 2025-06-30 | 13G | MERUS N V COM MRUS | Commodore Capital LP | 3,525,000 4.700% | -225,000 (-6.00%) | Filing History |
| 2025-08-14 5:06 pm Purchase | 2025-06-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Commodore Capital LP | 6,022,957 9.900% | 1,922,957 (+46.90%) | Filing History |
| 2025-08-14 5:06 pm Sale | 2025-06-30 | 13G | CARDIFF ONCOLOGY INC CRDF | Commodore Capital LP | 0 0.000% | -5,384,616 (Position Closed) | Filing History |